天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Wuhan Jingkangen Biomedical Technology Co., Ltd

Firmenname:Wuhan Jingkangen Biomedical Technology Co., Ltd
Telefon:13720134139 +86 -0-15871494362
E-Mail:orders@jknbiochem.com
Nationalit?t:China
URL: www.jknbiochem.com
Produkte insgesamt:5821
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59

Produktkatalog

TGX-221663619-89-4C21H24N4O2
PHA-767491(HCl)845714-00-3C12H11N3O
Ganetespib888216-25-9C20H20N4O3
Moclobemide (Ro 111163)71320-77-9C13H17ClN2O2
Ulocuplumab1375830-34-4
Brontictuzumab1447814-75-6
Research Grade Obexelimab1690307-05-1
Vandortuzumab Vedotin1471985-92-8
Amivantamab2171511-58-1
GSK 429286A864082-47-3C21H16F4N4O2
Sparsentan254740-64-2C32H40N4O5S
VR231624602-30-7C19H16ClN5O6S
Anetumab Ravtansine1375258-01-7
Fletikumab1357158-22-5
Abituzumab1105038-73-0
Lenzilumab1229575-09-0
Research Grade Tafasitamab1422527-84-1
CID 755673521937-07-5C12H11NO3
HMN-214173529-46-9C22H20N2O5S
LMK-2351418033-25-6C15H22N2O4
SB 366791472981-92-3C16H14ClNO2
Tirzepatide2023788-19-2
Tarextumab1359940-55-8
Anifrolumab1326232-46-5
Emibetuzumab1365287-97-3
Lumretuzumab1448327-63-6
SKF38393 HCl62717-42-4C16H17NO2
Eldelumab946414-98-8
Ralpancizumab1407495-04-8
Denintuzumab Mafodotin1399672-02-6
Lacutamab2187368-16-5
semaglutide99291-20-0C42H69N9O14S
GW0742317318-84-6C21H17F4NO3S2
A661166227-08-2C17H23N5O2S2
Apoptozole1054543-47-3C33H25F6N3O3
APS-2-792002381-31-7C23H22ClN3O3
mu-conotoxin936616-33-0C92H139N35O28S6
AG 490133550-30-8C17H14N2O3
Dapirolizumab Pegol1416147-64-2
Coltuximab Ravtansine1269764-99-9
Firivumab1443004-15-6
Lokivetmab1533403-95-0
Kartogenin4727-31-5C20H15NO3
Oprozomib;ONX-0912935888-69-0C25H32N4O7S
FPS-ZM1945714-67-0C20H22ClNO
KC7F2927822-86-4C16H16Cl4N2O4S4
HLCL-611158279-20-9C23H25ClN2O
Avelumab1537032-82-8
Reversine656820-32-5C21H27N7O
Scriptaid287383-59-9C18H18N2O4
Tovetumab1243266-04-7
Enfortumab Vedotin1346452-25-2
Pasotuxizumab1442657-12-6
Begelomab1403744-56-8
BLU-9452660250-10-0C28H37FN6O3S
SW-033291459147-39-8C21H20N2OS3
Daprodustat;GSK1278863960539-70-2C19H27N3O6
Idarucizumab1362509-93-0
Aducanumab1384260-65-4
Bimekizumab1418205-77-2
Guselkumab1350289-85-8
Tosatoxumab1374419-41-6
Bococizumab1407495-02-6
Vanucizumab1448221-05-3
Vitamin K2 (Mk7)2124-57-4C46H64O2
GW2580870483-87-7C20H22N4O3
Vidofludimus;4SC-101717824-30-1C20H18FNO4
Stattic19983-44-9C8H5NO4S
AZD94961639042-08-2C25H25F3N2O2
ON1233001357470-29-1C24H27N7O
CC1221015474-32-4C14H14N4O3
BMS-9861651609392-27-9C20H22N8O3
Otlertuzumab1372645-37-8
Go 6983133053-19-7C26H26N4O3
Sofituzumab Vedotin1418200-58-4
Ontuxizumab946415-62-9
Remtolumab1791410-27-9
Evinacumab1446419-85-7
3-Piperidinecarboxamide, N-(4,6-difluoro-2-benzothiazolyl)-1-[2-(dimethylamino)ethyl]-2747162-85-0C17H22F2N4OS
WP 1066857064-38-1C17H14BrN3O
BAY-57-1293;Pritelivir348086-71-5C18H18N4O3S2
Tazemetostat (EPZ-6438)1403254-99-8C34H44N4O4
BLU-99311538604-68-0C26H22Cl2N4O3
Durvalumab1428935-60-7
Atezolizumab1380723-44-3
Varlilumab1393344-72-3
dinutuximab1363687-32-4
UCB-92601515888-53-5C26H25N5O
Vantictumab1345009-45-1
Lifastuzumab Vedotin1401812-88-1
Lulizumab Pegol1421830-13-8
Imalumab1430205-07-4
PD 123319 ditrifluoroacetate136676-91-0C33H33F3N4O5
SB 742457607742-69-8C19H19N3O2S
SH-4-541456632-40-8C29H27F5N2O5S
Vobarilizumab1628814-88-9
Codrituzumab1365267-33-9
Margetuximab1350624-75-7
Abrilumab1342290-43-0
Emactuzumab1448221-67-7
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2019 ? ChemicalBook. All rights reserved